Trimitra Prawara Goldland Tbk. vs Merck Tbk. — how do they compare? Trimitra Prawara Goldland Tbk. trades at Rp555 (market cap 557.5B, 4.54M 24h volume), while Merck Tbk. trades at Rp3,740 (market cap 1.68T, 22.8K 24h volume). The key difference: Merck Tbk. is far larger — about 3× Trimitra Prawara Goldland Tbk.'s market cap, and Trimitra Prawara Goldland Tbk. is more actively traded (4.54M versus 22.8K). Which is the better fit depends on your goals.
| ATAP | MERK | |
|---|---|---|
Market Cap | 557.5B | 1.68T |
Volume | 4.54M | 22.8K |
Lot | 45.39K | 228 |
Turnover | 2.47B | 82.9M |
Average Price | 543.8 | 3,636.14 |
Value | 2.47B | 82.9M |
Indicative Equilibrium Price | 555 | 3,520 |
Indicative Equilibrium Volume | 104 | 60 |
Trailing returns across standard periods
Latest headlines on both assets
PT Trimitra Prawara Goldland Tbk (the Company) was established in Indonesia based on Notarial Deed No. 13 of Dede Munajat, S.H., on March 23, 2015 a Notary in Bogor. The Company started its commercial operations in 2015.
Read more on ATAP →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →